Progress in the Concussion Community: Three Milestones in 2023

As we prepare to bid farewell to 2023, it’s worth reflecting on some of the year’s key milestones in the field of concussion. The year brought advancements in awareness as well as progress in diagnosis and treatment that shed further light on the physical and cognitive toll these injuries can have on individuals. Three of this year’s milestones in concussion:

SCAT6 – the next generation of sports concussion diagnostic

A landmark development in concussion management, the most recent iteration of the Sport Concussion Assessment Tool, known as SCAT6, was published this year in the British Journal of Sports Medicine. The SCAT6 is a thoroughly researched, standardized, and evidence-based tool used in the assessment and management of concussions in athletes. Read our blog post on it here.

Women’s World Cup added concussion spotters for the first time.

This year, the Women’s World Cup introduced independent concussion spotters for the first time. Concussion spotters are medical personnel tasked with monitoring games to detect concussions. Using slow motion video technology, they assess collisions and evaluate post-collision player movements. If signs of concussion appear, they alert team doctors We covered the changes in our own blog post in August.

3. Canada launched the TRANSCENDENT Concussion research program

The TRANSCENDENT Concussion Research program was officially funded in 2023. The program is aimed at improving concussion diagnosis and care. The TRANSCENDENT Team consists of leading concussion researchers who will collaborate to expand the concussion research databases to be one of the largest. Oculogica’s EyeBOX technology will be a part of this important multi-year research effort.

2023 saw significant steps toward improving the likelihood of both avoiding and recovering from concussion. From heightened awareness and education to technological breakthroughs and improved sports protocols, the collective effort to understand and address concussions has never been more robust. As we look ahead, maintaining momentum is crucial as is fostering a culture that prioritizes the health and safety of individuals in both sports and everyday life.

EyeBOX^® is the first FDA cleared concussion assessment that does not require a baseline test

Request Demo

First Name(Required)

Last Name(Required)

Email(Required)

Organization(Required)

Phone(Required)

City(Required)

State/Country (If Outside US)

Preferred demonstration date and time and anything else you’d like to share about your interest:

I would like to subscribe to Oculogica's mailing list.

How did you hear about us?

Please tell us more

What was your search term?

I consent to receive SMS text messages to my cell number provided above for notifications, alerts, and general communication purposes, including promotions from Oculogica. I understand that I am not required to provide my consent as a condition of purchasing products or services. I understand that I can opt-out of receiving text messages at any time by responding with STOP. I can reply with HELP to get help. Message and data rates may apply depending on your mobile carrier. T-Mobile and other mobile carriers are not liable for delayed or undelivered messages.

Name

This field is for validation purposes and should be left unchanged.

EyeBOX® is the first FDA cleared concussion assessment that does not require a baseline test

Request Demo

EyeBOX^® is the first FDA cleared concussion assessment that does not require a baseline test